Panel Discussion: Exploring More Objective Ways of Classifying IBD Subtypes to Improve Patient Stratification
Time: 11:00 am
day: Day One
A session dedicated to discussing the future of risk-classifying IBD patients and tackling the need for more objective classifications.
- Discovering genetic signatures, microbiome patterns and proteomic indicators to formulate more homogenous patient groups to increase therapeutic efficacy within that patient group
- Exploring novel scores to effectively measure burden of disease to better understand the patient need to inform therapeutic decisions
- Addressing inconsistencies within the field regarding categorization of IBD subtypes to ensure novel discoveries are applicable across clinical settings